Navigation Links
Biosimilar Monoclonal Antibodies in Oncology Will Approach Blockbuster Status by 2017
Date:10/14/2008

Opportunity for Biosimilars Varies Significantly by Therapeutic Area,

According to a New Report from Decision Resources

WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake of biosimilar monoclonal antibodies (MAbs) in oncology will drive robust sales of drugs within this class. The most notable near-term biosimilar targets for MAbs in oncology are Genentech/Roche's Herceptin and Rituxan/MabThera.

The new special report Biosimilars 2007-2017: Shifting Payer and Physician Opinion Increases the Hurdles to Uptake forecasts that sales of biosimilar Herceptin will approach blockbuster status in 2017 in Europe alone, and biosimilar Rituxan/MabThera will garner $940 million in sales by 2017 in the United States, France, Germany, Italy, Spain and the United Kingdom. Based on the success of branded Herceptin and Rituxan/MabThera, near-term opportunity exists for drug manufacturers investing in the development of biosimilar MAbs in oncology. The report finds that oncologists will be among the most aggressive users of biosimilar drugs, and the high turnover of oncology patients will accelerate growth and penetration within the relatively un-crowded biosimilar MAb market.

Although oncology will prove to be a robust market, the opportunity for biosimilars varies significantly by therapeutic area, according to the report. For example, owing to an increasingly cautious attitude among neurologists regarding safety and efficacy associated with the use of biosimilars in chronic diseases like multiple sclerosis, the expectations for biosimilar interferon-betas in neurology remain tempered. Additionally, the emergence of novel multiple sclerosis therapies will constrain interferon-beta use over the long-term; prior to biosimilar entry, forecasted sales of interferon-betas in the United States and European Union wil
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
2. The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016
3. Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
4. Monoclonal antibody Hb3: A marker for colon cancer progression or as a therapeutic target?
5. Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
6. Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
7. Study Shows Mothers Who Take Chlorella Boost Babies Antibodies During Breast Feeding
8. Researchers Develop Quick Way to Create Human Antibodies
9. Anti-HAV antibodies in beta-thalassemia
10. Vegan diet promotes atheroprotective antibodies in patients with rheumatoid arthritis
11. Autoantibodies and neuropsychiatric events in lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... policy that bans blood donations from gay and bisexual men, according ... in the Journal of the American Medical Association . ... cannot donate blood in the United States -- a lifetime ban ... and Drug Administration adopted this policy at the dawn of the ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... "We experienced difficulty filling our pill ... two inventors from Jamestown, Calif. "We came up with ... we could pour medications in more easily." , They ... keep the lids open as the pill box is ... compartments have been filled. This eliminates hassles and frustrations, ...
(Date:7/28/2014)... 28, 2014 Scientists in Japan have ... improved blood test for the asbestos cancer mesothelioma. Surviving ... research. Click here to read it now. ... Tokyo’s Juntendo University Graduate School of Medicine say a ... a step above the old test. , “Particularly ...
(Date:7/28/2014)... Hill, South Carolina (PRWEB) July 28, 2014 ... people enjoy their first bite of food best, with ... before. Over-indulging, the researchers found, can actually serve to ... to overindulge in foods they enjoy, not realizing the ... statement. "This is the argument for moderation, if we ...
Breaking Medicine News(10 mins):Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3
... MIAMI, Oct. 8 Infants and toddlers cannot ... on over-the-counter children,s,medicines, parents need a safe alternative ... been the bulb aspirator. However, these can,irritate a ... In-the-know parents have discovered the safe, effective alternative,that,s ...
... treatment for breast cancer differs between African-American women and ... insurance type. The study appears in the November 15, ... American Cancer Society. , Dr. Mousumi Banerjee of ... from Wayne State University and Dr. William Hryniuk from ...
... progression of age-related macular degeneration (AMD), according to a ... Human Nutrition Research Center on Aging at Tufts University. ... in 7 to 15% of the elderly, according to ... be the most practical and cost-effective prevention method to ...
... BEND, Ind., Oct. 7 OCS, Inc. and,Press ... into a,partnership, whereby the companies have combined their ... of products for the home,health care industry. The ... analysis of interrelated performance metrics integrating,patient satisfaction, patient ...
... The following is a,transcript of a radio address by ... morning., One important commitment of the Federal government ... care. Most of these children are,covered by Medicaid, which ... fiscal year. For children who do not qualify for ...
... Studies link this common problem with vascular disease , , ... realize it, but if they,re having problems achieving or ... Erectile dysfunction, or impotence, affects more than 18 million ... at the Johns Hopkins Bloomberg School of Public Health. ...
Cached Medicine News:Health News:As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines 2Health News:Differences observed between black and white women in use of breast cancer therapy 2Health News:Limiting refined carbohydrates may stall AMD progression 2Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Radio Address by President Bush to the Nation 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
(Date:7/25/2014)... 2014  In today,s marketplace, launching multiple products for ... as is managing a portfolio of products in the ... - or even preferable - to pool resources to ... combine resources and activities, and what marketing and sales ... just a few of the dilemmas facing pharmaceutical sales, ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... and INGELHEIM, Germany, July 6, 2011 As part ... the most promising solutions to challenging health problems around ... the launch of the Making More Health: Achieving ... This worldwide competition invites the most ...
... Inc. (NYSE: RMD and ASX: ... medical equipment for treating, diagnosing and managing sleep-disordered ... it has acquired BiancaMed Ltd., a leading Irish ... outstanding shares with cash.   (Logo: ...
Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3ResMed Announces Acquisition of BiancaMed 2ResMed Announces Acquisition of BiancaMed 3
The Achieva CV brings the power of CMR into routine clinical practice, so you can do more in Cardiovascular MR....
The Clearblue Easy Digital Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the...
These products are primarily for use with paediatric patients and for patients with difficult veins....
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: